PL379549A1 - Autologiczne, indukujące tolerancję na antygeny własne komórki pochodzenia monocytarnego oraz ich zastosowanie w preparatach farmaceutycznych - Google Patents

Autologiczne, indukujące tolerancję na antygeny własne komórki pochodzenia monocytarnego oraz ich zastosowanie w preparatach farmaceutycznych

Info

Publication number: PL379549A1
Authority: PL; Poland
Prior art keywords: cells; autologous; pharmaceutical preparations; antigens; monocytic origin
Prior art date: 2003-07-11

Application number

PL379549A

Other languages

English (en)

Inventor

Bernd Karl Friedrich Kremer

Fred FÄNDRICH

Maren Schulze

Original Assignee

Blasticon Biotechnologische Forschung Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-11

Filing date

2004-01-09

Publication date

2006-10-16

2003-07-11 Priority claimed from PCT/EP2003/007551 external-priority patent/WO2004007701A1/en

2004-01-09 Application filed by Blasticon Biotechnologische Forschung Gmbh filed Critical Blasticon Biotechnologische Forschung Gmbh

2006-10-16 Publication of PL379549A1 publication Critical patent/PL379549A1/pl

Links

239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
230000001939 inductive effect Effects 0.000 title 1
210000004027 cell Anatomy 0.000 abstract 3
208000023275 Autoimmune disease Diseases 0.000 abstract 1
206010020751 Hypersensitivity Diseases 0.000 abstract 1
230000007815 allergy Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
210000003289 regulatory T cell Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/22—Immunosuppressive or immunotolerising
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/418—Antigens related to induction of tolerance to non-self
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Hematology (AREA)
Microbiology (AREA)
Diabetes (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Mycology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)

PL379549A 2003-07-11 2004-01-09 Autologiczne, indukujące tolerancję na antygeny własne komórki pochodzenia monocytarnego oraz ich zastosowanie w preparatach farmaceutycznych PL379549A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/EP2003/007551 WO2004007701A1 (en)	2002-07-12	2003-07-11	Transplant acceptance inducing cells of monocytic origin and their preparation and use

Publications (1)

Publication Number	Publication Date
PL379549A1 true PL379549A1 (pl)	2006-10-16

Family

ID=34042673

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL379549A PL379549A1 (pl)	2003-07-11	2004-01-09	Autologiczne, indukujące tolerancję na antygeny własne komórki pochodzenia monocytarnego oraz ich zastosowanie w preparatach farmaceutycznych

Country Status (15)

Country	Link
US (1)	US20060188485A1 (pl)
EP (1)	EP1644484B1 (pl)
JP (1)	JP2007525473A (pl)
KR (1)	KR20060040671A (pl)
CN (1)	CN1823160A (pl)
AT (1)	ATE408670T1 (pl)
AU (1)	AU2004256154A1 (pl)
BR (1)	BRPI0412506A (pl)
CA (1)	CA2531627A1 (pl)
DE (1)	DE602004016664D1 (pl)
DK (1)	DK1644484T3 (pl)
NO (1)	NO20060637L (pl)
PL (1)	PL379549A1 (pl)
RU (1)	RU2346041C2 (pl)
WO (1)	WO2005005620A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1944361A1 (en) *	2007-01-11	2008-07-16	INSERM (Institut National de la Santé et de la Recherche Médicale)	A method for expanding monocytes
US20100167399A1 (en) *	2008-12-29	2010-07-01	Loyola University Chicago	Method of generating regulatory t cells using cord blood and adult blood cd14+ monocyte cells
RU2435556C1 (ru) *	2010-04-23	2011-12-10	Владимир Васильевич Лантух	Способ лечения дистрофических заболеваний заднего полюса глаза
JP5771917B2 (ja) *	2010-08-04	2015-09-02	公益財団法人ヒューマンサイエンス振興財団	単核球分離管及び単核球分離システム
CA3023092A1 (en) *	2016-05-03	2017-11-09	Sqz Biotechnologies Company	Intracellular delivery of biomolecules to induce tolerance
CA3153128A1 (en) *	2019-10-11	2021-04-15	Katja Annina PUTTONEN	New regulatory macrophages and uses thereof
CN110904024A (zh) *	2019-11-13	2020-03-24	武汉济源高科技有限公司	一种悬浮细胞培养中去除死细胞的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5766920A (en) *	1982-08-11	1998-06-16	Cellcor, Inc.	Ex vivo activation of immune cells
US9068164B1 (en) *	1995-02-02	2015-06-30	Tristem Trading (Cyprus) Limited	Method of preparing an undifferentiated cell
GB9502022D0 (en) *	1995-02-02	1995-03-22	Abuljadayel Ilham M S	A method for preparing lymphohaematopoietic progenitor cells
US7410773B2 (en) *	1995-02-02	2008-08-12	Ghazi Jaswinder Dhoot	Method of preparing an undifferentiated cell
US7112440B2 (en) *	1995-02-02	2006-09-26	Ghazi Jaswinder Dhoot	Method of increasing the relative number of CD45 low cells in a cell population
CA2214649C (en) *	1995-03-08	2007-06-12	Zeling Cai	Antigen presenting system and methods for activation of t-cells
NL1017973C2 (nl) *	2000-05-10	2002-11-08	Tristem Trading Cyprus Ltd	Inrichting.
JP2004527263A (ja) *	2001-05-30	2004-09-09	フォンダツィオーネテレソン	免疫抑制活性を有するエクスビボ単離ｃｄ２５＋ｃｄ４＋ｔ細胞とその使用
TWI288779B (en) *	2002-03-28	2007-10-21	Blasticon Biotech Forschung	Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
DE10231655A1 (de) *	2002-07-12	2004-02-26	Blasticon Biotechnologische Forschung Gmbh	Transplantat-Akzeptanz induzierende Zellen monozytären Ursprungs, sowie deren Herstellung und Verwendung

2004
- 2004-01-09 US US10/563,956 patent/US20060188485A1/en not_active Abandoned
- 2004-01-09 EP EP04701001A patent/EP1644484B1/en not_active Expired - Lifetime
- 2004-01-09 DE DE602004016664T patent/DE602004016664D1/de not_active Expired - Fee Related
- 2004-01-09 BR BRPI0412506-1A patent/BRPI0412506A/pt not_active IP Right Cessation
- 2004-01-09 DK DK04701001T patent/DK1644484T3/da active
- 2004-01-09 PL PL379549A patent/PL379549A1/pl not_active Application Discontinuation
- 2004-01-09 AU AU2004256154A patent/AU2004256154A1/en not_active Abandoned
- 2004-01-09 KR KR1020067000579A patent/KR20060040671A/ko not_active Ceased
- 2004-01-09 WO PCT/EP2004/000109 patent/WO2005005620A1/en not_active Ceased
- 2004-01-09 AT AT04701001T patent/ATE408670T1/de not_active IP Right Cessation
- 2004-01-09 RU RU2006104112/15A patent/RU2346041C2/ru active
- 2004-01-09 CN CNA2004800198394A patent/CN1823160A/zh active Pending
- 2004-01-09 CA CA002531627A patent/CA2531627A1/en not_active Abandoned
- 2004-01-09 JP JP2006517974A patent/JP2007525473A/ja active Pending
2006
- 2006-02-09 NO NO20060637A patent/NO20060637L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE602004016664D1 (de)	2008-10-30
BRPI0412506A (pt)	2006-09-05
RU2006104112A (ru)	2006-08-27
ATE408670T1 (de)	2008-10-15
EP1644484A1 (en)	2006-04-12
HK1088926A1 (en)	2006-11-17
AU2004256154A1 (en)	2005-01-20
US20060188485A1 (en)	2006-08-24
CN1823160A (zh)	2006-08-23
KR20060040671A (ko)	2006-05-10
CA2531627A1 (en)	2005-01-20
EP1644484B1 (en)	2008-09-17
WO2005005620A1 (en)	2005-01-20
JP2007525473A (ja)	2007-09-06
RU2346041C2 (ru)	2009-02-10
DK1644484T3 (da)	2009-01-05
NO20060637L (no)	2006-04-03

Legal Events

Date	Code	Title	Description
2011-06-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
SG166093A1 (en)	2010-11-29	Inhibitors of brutonæs tyrosine kinase
HUP0103182A2 (hu)	2002-01-28	Dialkil-fumarátok alkalmazása transzplantációs kezelésekben használható gyógyászati készítmények előállítására
CY1119369T1 (el)	2018-02-14	Ιατρικα παρασκευασματα για τη θεραπευτικη αγωγη της ανεπαρκειας της αλφα-γαλακτοσιδασης α
UA105210C2 (ru)	2014-04-25	Противораковая вакцина и ее применение
IL172854A0 (en)	2006-06-11	Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations
NO20015584L (no)	2002-01-03	Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
ATE308331T1 (de)	2005-11-15	Kombinationspräparat enthaltend monozyten- abgeleitete zellen zur behandlung von neoplastischen oder infektiösen erkrankungen
TR201903587T4 (tr)	2019-04-22	Telomeraz aktivitesinin artırılması için bileşimler.
DK0703786T3 (da)	2002-05-27	Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
AR024074A1 (es)	2002-09-04	FRAGMENTO ABETA UNIDO A UN PÉPTIDO PORTADOR PARA PREVENIR O TRATAR ENFERMEDADES ASOCIADAS CON DEPoSITOS AMILOIDES DE ABETA, COMPOSICIONES FARMACÉUTICAS QUE LO CONTIENEN, Y SU USO EN LA PREPARACION DE MEDICAMENTOS.
AR034213A1 (es)	2004-02-04	Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
CY1118073T1 (el)	2017-06-28	Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης
MX2009006327A (es)	2009-06-23	Compuestos heterociclicos y metodos de uso de los mismos.
BRPI0508700A (pt)	2007-08-07	uso de sns-595, composição farmacêutica, e, pó liofilizado
DE602004023183D1 (de)	2009-10-29	Gegen antikörper gerichtete photodynamische therapie
SE0300098D0 (sv)	2003-01-15	Use of cyclin D1 inhibitors
JO2229B1 (en)	2004-10-07	Stem cells are programmable, distinctly regenerative, of single-core cell origin, production, and use
DE60137146D1 (de)	2009-02-05	Fusionszellen und zytokin-zusammensetzungen zur behandlung von krankheiten
EA200702522A1 (ru)	2008-04-28	Система доставки лекарств в полость рта и способы ее применения
PL379549A1 (pl)	2006-10-16	Autologiczne, indukujące tolerancję na antygeny własne komórki pochodzenia monocytarnego oraz ich zastosowanie w preparatach farmaceutycznych
NO20073132L (no)	2007-08-29	Fremstilling av proteiner
NO20034417D0 (no)	2003-10-02	Engangs vaginalkanyle for samtidig administrasjon av medikamenter i ulike former
DK1596879T3 (da)	2011-04-11	Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
ATE433459T1 (de)	2009-06-15	Desoxo-nonadepsipeptide
SI1869185T1 (sl)	2010-09-30	Konjugat ki obsega protein P za zdravljenje raka